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Innovations in Practice: The relationship between
sleep disturbances, depression, and interpersonal
functioning in treatment for adolescent depression
Eleanor L. McGlinchey, Jazmin A. Reyes-Portillo, J. Blake Turner & Laura Mufson
Division of Child and Adolescent Psychiatry, Columbia University Medical Center, New York State Psychiatric Institute,
1051 Riverside Drive Box 78, New York City, NY, USA. E-mail: mcglinc@nyspi.columbia.edu

Background: Sleep disturbance is frequently comorbid with depression and sleep complaints are the most
common residual symptoms after treatment among adolescents with depression. The present analyses investigated the effect of sleep disturbance in depressed adolescents treated with interpersonal psychotherapy for
adolescents (IPT-A) versus treatment as usual (TAU) in school-based mental health clinics. Method: Sixty-three
adolescents participated in a randomized clinical trial of IPT-A versus TAU for adolescent depression. Participants were diagnosed with a DSM-IV depressive disorder and assessed for symptoms of depression, interpersonal functioning, and sleep disturbance. Measures were assessed at baseline, session 4 and 8 of treatment,
and session 12 for postacute treatment follow-up. Hierarchical linear modeling was used to model change in
depression, interpersonal functioning, and sleep disturbance. Results: Ongoing sleep disturbance was significantly associated with worse depression scores as rated by clinician (c = 1.04, SE = .22, p < .001) and self-report
(c = 1.63, SE = .29, p < .001), as well as worse interpersonal functioning across the course of treatment
(c = 0.09, SE = .02, p < .001). Treatment condition did not predict change in sleep disturbance (c = 0.13,
SE = .14, p = ns). Conclusions: For all patients in the study, sleep disturbance was a predictor of depression
and interpersonal functioning for depressed adolescents. Sleep disturbance predicted more depression and
interpersonal stress across treatments and led to a slower improvement in depression and interpersonal functioning. These data suggest that sleep disturbance should be a target for future treatment development
research among depressed adolescents.

Key Practitioner Message

•
•
•
•

Sleep disturbance is a precursor to the onset of depression among adolescents.
Residual sleep difficulties are a major component of persistent depressive symptoms after acute treatment
and further increase the risk of depression episode relapse.
This study found that sleep disturbance was significantly associated with worse depression scores across the
course of a treatment trial as rated by clinician and adolescent self-report.
This study highlights the importance of addressing sleep disturbance during treatment in order to improve
psychotherapy outcomes for depressed adolescents.
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Introduction
While substantial progress in treatment for adolescent
depression has been made, even the best treatments
achieve 50–70% response rates, leaving much room for
improvement (Weisz, McCarty, & Valeri, 2006). Interpersonal psychotherapy for depressed adolescents (IPT-A;
Mufson et al., 2004) is an evidence-based psychotherapy that aims to reduce adolescents’ depressive symptoms by helping them improve their relationships.
Identifying factors that further enhance IPT-A outcomes
may help guide clinicians in treatment planning and
focus.
The accumulated evidence makes a strong case for the
relevance of sleep difﬁculties in adolescent depression
treatment. Depression and insomnia are highly comorbid (Wolfson & Carskadon, 1998). Adolescent insomnia

typically precedes a major depressive episode and predicts its onset in longitudinal studies (Lovato & Gradisar, 2014). Insomnia that is concurrent with a major
depressive episode is associated with poorer response to
treatment for active depression in adults (Thase,
Simons, & Reynolds, 1996) and in adolescents treated
with medication (Emslie et al., 2012). Finally, residual
insomnia is a major component of persistent depressive
symptoms after acute treatment in both adolescents
(Kennard et al., 2006) and adults (Becker, 2006), and
further increases the risk of depression relapse (Dombrovski et al., 2008).
Recent evidence suggests that interpersonal distress
is associated with more sleep complaints and greater
insomnia severity (Gunn, Troxel, Hall, & Buysse, 2014).
Sleep difﬁculties are not directly targeted in IPT-A, however, given the interpersonal targets of IPT-A, sleep may
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be a mediator of positive IPT-A response. To our knowledge, no previous literature has examined sleep disturbance as a mediator of IPT-A.
The goal of this secondary data analysis was to examine sleep as a potential mechanism by which IPT-A
works to improve adolescent depression. This question
was examined using data from a school-based, randomized controlled trial of IPT-A versus treatment as usual
for adolescent depression (TAU; Mufson et al., 2004). We
sought to determine if there is a reduction in reported
sleep disturbance over the course of treatment for adolescent depression and whether this reduction is greater
in IPT-A relative to TAU. The hypothesis was that
improvements in depression resulting from IPT-A would
be partially mediated by improvements in sleep.
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Data analytic strategy. We analyzed data using growth
curve modeling in STATA 12 SE software (STATA version 12;,
Texas Corp., College Station, TX). A series of models were ﬁt to
the HRSD data (sleep items removed), the BDI data (sleep item
removed) and the SAS-SR data to determine the shape of the
trajectory of patients’ change in depression and interpersonal
functioning throughout treatment.
Missing data. A high response rate was achieved. The

ﬁnal data set consisted of 236 sleep disturbance measurements (94% of the possible total of 252), 228 HRSD measurements (91% of the possible total of 252), 236 BDI
measurements (94% of the possible total of 252), and 236
SAS-SR measurements (94% of the possible total of 252).
There were no differences between treatment groups in the
mean number of measurements. If one or more of the
measurements had a missing value, that observation was
omitted from the model analysis.

Method
Participants
Participants were 63 depressed adolescents (12–18 years old)
participating in a clinical trial examining the effectiveness of
IPT-A compared to TAU for the treatment of depression (Mufson
et al., 2004). The sample had a mean age of 15.1 years (SD,
1.9 years), and was 84% female and 71% Hispanic. Comorbid
diagnoses were 20 patients (32%) with anxiety disorders, 5 (8%)
with oppositional deﬁant disorder, 10 (16%) with substance
use, and 4 (6%) with attention-deﬁcit/hyperactivity disorder.
Adolescents were referred for treatment in ﬁve school-based
health clinics in New York City. The study was approved by the
institutional review boards for the three hospitals that sponsored the ﬁve school-based mental health clinics and by the
New York City Board of Education. Informed consent and
assent was required for participation. See Mufson et al. (2004)
for a complete description of the trial and the Consolidated
Standards of Reporting Trials (CONSORT) ﬂowchart.

Treatment
Adolescents were randomized to receive IPT-A or TAU. IPT-A is a
12-session, evidence-based psychotherapy that aims to
decrease depressive symptoms by helping adolescents improve
their relationships and interpersonal interactions (Mufson
et al., 2004). TAU was whatever psychological treatment adolescents normally would have received in the school-based clinic.

Procedures and measures
A psychologist or social worker blind to the youth’s treatment conducted assessments at baseline, weeks 4, 8, and
12; or at early termination. The Schedule for Affective
Disorders and Schizophrenia for School-Age Children
(KSADS; Kaufman et al., 1997) was used to assess current
diagnoses on the basis of DSM–IV diagnostic criteria (American Psychiatric Association, 1994). Depressive symptoms
were assessed using the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1967) and the Beck Depression
Inventory (BDI-II; Beck, Steer, & Carbin, 1988). In the current analyses, sleep items were removed from the HRSD
and BDI and their scores were summed without these
items. Interpersonal functioning was assessed with the
Social Adjustment Scale–Self-Report (SAS-SR; Weissman &
Bothwell, 1976). Cronbach’s alphas for the HRSD, BDI, and
SAS-SR were .74, .88, and .67, respectively (Table 1).
Symptoms of sleep disturbance were assessed via three items
from the clinician-rated HRSD (Hamilton, 1967). The three
items were 0–2 ratings of: (a) difﬁculty falling asleep, (b) difﬁculty staying asleep, and (c) waking too early and not being able
to fall back to sleep. Higher ratings indicated more severe sleep
difﬁculties. Items were summed to create a composite sleep
score at each assessment point. Previous work indicates that
the HRSD sleep items are highly correlated with sleep diary
reports of insomnia symptoms (Manber et al., 2005).
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Results
At baseline, 65% of trial participants reported nightly
sleep difﬁculties over the previous 2 weeks (a score of
two on at least one of the three HRSD sleep items). For
the HRSD, BDI, and SAS-SR, the quadratic model was
a signiﬁcantly better ﬁt to the data than the linear
model based on chi-square comparison (HRSD Dv2(4,
N = 63) = 18.49, p = .001; BDI Dv2(4, N = 63) = 9.46,
p < .01, SAS-SR Dv2(4, N = 63) = 2.73, p < .05), thus
the quadratic model was selected for all subsequent
analyses. Next, treatment condition (IPT-A vs. TAU) was
added to the model. The effect of treatment was signiﬁcant for the HRSD, but not for the BDI and SAS-SR.
However, the treatment condition variable signiﬁcantly
improved the model ﬁt over the baseline quadratic
model for the HRSD, BDI, and SAS-SR (HRSD Dv2(4,
N = 63) = 9.65, p < .01, BDI Dv2(4, N = 63) = 8.25,
p < .05, SAS-SR Dv2(4, N = 63) = 9.10, p < .01; See
Table 2). Together, these ﬁndings indicate that depression symptomatology over the course of treatment was
effected by the type of treatment a patient received.

Sleep disturbance as a predictor of depressive
symptoms and interpersonal functioning
The sleep disturbance variable was added as a timevarying predictor to the model. There were signiﬁcant
effects of reported sleep disturbance; over the course of
treatment, sleep disturbance was associated with
increases in HRSD, BDI, and SAS-SR scores (See
Table 2). These models were a better ﬁt to the data than
those with treatment condition alone (HRSD Dv2(4,
N = 63) = 28.19, p < .001; BDI Dv2(4, N = 63) = 44.14,
p < .001, SAS-SR Dv2(4, N = 63) = 30.04, p < .001).

Model of treatment condition predicting change in
sleep disturbance
Quadratic change in reported sleep disturbance was
modeled as a function of treatment group membership
in order to further test our hypothesis that IPT-A would
have a more signiﬁcant effect on sleep disturbance than
TAU. The linear and quadratic ﬁxed effects were not signiﬁcant, indicating that sleep disturbance did not significantly change over the course of treatment for either
treatment condition. Moreover, treatment condition was
not a signiﬁcant predictor of changes in sleep disturbance scores over the course of treatment (See Table 2).
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Table 1. Adolescents’ mean baseline depression symptoms, sleep disturbance, clinical severity, and intercorrelations

Variable

HRSD total
(sleep items removed)

BDI total
(sleep item removed)

SAS-SR total
score

HRSD sum of
sleep items

BDI sleep item

16.25 (4.75)
–
0.54***
0.40**
0.29*
0.26*

20.52 (8.43)

2.83 (0.50)

2.38 (1.73)

1.13 (0.89)

M (SD)
HRSD total (sleep items removed)
BDI total (sleep item removed)
SAS-SR total Score
HRSD sum of sleep items
BDI sleep item

–
0.38**
0.43***
0.47***

–
0.22
0.20

–
0.58***

–

Higher scores on all measures indicate more symptoms and worse functioning. HRSD, Hamilton Rating Scale for Depression; BDI, Beck
Depression Inventory-II; SAS-SR, Social Adjustment Scale-Self Report.
*p < .05; **p < .01; ***p < .001.

Table 2. Parameters for treatment condition alone (model 1) and treatment condition and sleep disturbance (model 2) predicting depression and interpersonal functioning change over 12 sessions of treatment
Model 1

Parameter
Intercept, c00
Treatment group
(IPT-A), c01
Linear change (time), c10
Treatment group
(time by treatment
interaction), c11
Quadratic change
(quadratic time), c20
Treatment group
(quadratic time by
treatment interaction), c21
Sleep disturbance
(time-varying), c30
Treatment
(sleep by treatment
interaction), c31
†

Model 2

HRSD
Unstandardized
coefficient (SE)

BDI
Unstandardized
coefficient (SE)

SAS-SR
Unstandardized
coefficient (SE)

HRSD
Unstandardized
coefficient (SE)

BDI
Unstandardized
coefficient (SE)

SAS-SR
Unstandardized
coefficient (SE)

16.11*** (0.97)
0.21 (1.34)

20.68*** (1.51)
0.80 (2.08)

2.77*** (0.10)
0.09 (0.14)

13.85*** (1.04)
0.20 (1.24)

17.46*** (1.52)
1.66 (1.79)

2.55*** (0.11)
0.09 (0.13)

0.92** (0.29)
0.76* (0.39)

1.35*** (0.33)
0.73† (0.46)

0.008 (0.03)
0.04 (0.04)

0.89** (0.28)
0.68† (0.39)

1.27*** (0.34)
0.61 (0.46)

0.01 (0.02)
0.04† (0.03)

0.04 (0.02)

0.05† (0.03)

0.002 (0.002)

0.04† (0.02)

0.04 (0.03)

0.002 (0.002)

0.03 (0.03)

0.03 (0.03)

0.0003 (0.003)

0.03 (0.03)

0.03 (0.04)

0.0004 (0.003)

1.04*** (0.22)

1.63*** (0.29)

0.09*** (0.02)

0.07 (0.44)

0.17 (0.58)

0.05 (0.04)

p < .10; *p < .05; **p < .01; ***p < .001.

Discussion
This study aimed to assess the role of reported sleep disturbance in treatment outcome for depressed adolescents undergoing 12 weeks of psychotherapy (IPT-A vs.
TAU) in school-based health clinics. Contrary to our prediction, neither treatment condition led to changes in
sleep over the course of treatment. However, sleep disturbance over the 12 weeks of treatment was associated
with more depression and interpersonal stress at each
assessment point for both conditions. The results from
this analysis suggest that although sleep does not mediate IPT-A treatment outcome, changes in sleep are
indeed related to improvement in adolescents receiving
psychotherapy for depression, regardless of type of treatment. It is possible that sleep disturbance may signal a
more severe form of depression in teens given that these
symptoms also appear to be more resistant to treatment.
Although evidence suggests that interpersonal distress is associated with both depression (Rudolph et al.,
2000) and poor sleep (Gunn et al., 2014), it is likely that
in order for sleep to consistently improve during treatment, a speciﬁc focus on the relationship between

interpersonal stress and sleep should be addressed. Our
results suggest that sleep disturbance functions independently of current treatment targets in IPT-A, which
is consistent with evidence that sleep does not improve
in other evidence-based treatments for adolescent
depression (Kennard et al., 2006). This trial was not
designed to target sleep disturbance. However, given
that both treatment condition and sleep disturbance
independently were predictors of treatment outcome for
depression symptoms and interpersonal functioning
difﬁculties, it seems likely that addressing sleep disturbance in the context of interpersonal stress may lead to
more robust treatment outcomes for adolescent depression. A greater focus on sleep disturbance and its underlying mechanisms in the context of treatments for
depression will be an important area for future research,
particularly among adolescents where sleep disturbance
is prevalent and the mechanisms of its effect on depression are complex (Wolfson & Carskadon, 1998).
We also found that sleep disturbance predicted more
depression and interpersonal stress over the course of
treatment. This evidence further suggests the need to
support new adaptations of current treatments for
© 2016 Association for Child and Adolescent Mental Health.
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adolescent depression to target both depression and
sleep disturbance. A recent pilot study found support for
such an adaptation. Clarke et al. (2015) found that combining Cognitive Behavior Therapy for youth depression
(CBT-D) with CBT for insomnia versus CBT-D alone
resulted in medium-large effects of the combined treatment for improving sleep and depression outcomes. The
current study lends additional support for conducting
larger scale trials combining depression and sleep treatments for adolescents with depression.
Several limitations are important to consider. First,
the relatively small sample size may have limited statistical power. Second, gold standard measurements of sleep
variables were not used in this study. However, the use
of the HRSD clinician administered questions on sleep
has been done in previous studies on the impact of sleep
disturbance on treatment outcomes (McCall, Reboussin,
& Cohen, 2000) and previous work in depression has
found that the HRSD sleep items are highly correlated
with sleep diary parameters (Manber et al., 2005).
Nonetheless, a follow-up study should attempt to use
gold standard sleep measures to replicate results.

Conclusion
The results support the hypothesis that sleep disturbance is strongly predictive of treatment outcome for
adolescent depression. However, IPT-A is not mediated
by changes in sleep. These ﬁndings suggest that sleep
disturbance should be a target for future treatment
development research in adolescent depression. An
important next step will also be to examine the long-term
effects of continued sleep disturbance after acute treatment for depression and whether offering additional sessions focused on treating the sleep disturbance could
enhance long-term outcomes.
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